These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 18328268)
1. Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1. Xiong X; Cui P; Hossain S; Xu R; Warner B; Guo X; An X; Debnath AK; Cowburn D; Kotula L Biochim Biophys Acta; 2008 May; 1783(5):737-47. PubMed ID: 18328268 [TBL] [Abstract][Full Text] [Related]
2. Abi1/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cells. Dubielecka PM; Machida K; Xiong X; Hossain S; Ogiue-Ikeda M; Carrera AC; Mayer BJ; Kotula L FEBS Lett; 2010 Aug; 584(15):3279-86. PubMed ID: 20598684 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK. Jung JH; Pendergast AM; Zipfel PA; Traugh JA Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990 [TBL] [Abstract][Full Text] [Related]
4. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain. Brasher BB; Roumiantsev S; Van Etten RA Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core. Chen S; O'Reilly LP; Smithgall TE; Engen JR J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435 [TBL] [Abstract][Full Text] [Related]
7. Identification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1. Sato M; Maruoka M; Yokota N; Kuwano M; Matsui A; Inada M; Ogawa T; Ishida-Kitagawa N; Takeya T FEBS Lett; 2011 Mar; 585(6):834-40. PubMed ID: 21320496 [TBL] [Abstract][Full Text] [Related]
8. Role of the adapter protein Abi1 in actin-associated signaling and smooth muscle contraction. Wang T; Cleary RA; Wang R; Tang DD J Biol Chem; 2013 Jul; 288(28):20713-22. PubMed ID: 23740246 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma. Kumar S; Lu B; Dixit U; Hossain S; Liu Y; Li J; Hornbeck P; Zheng W; Sowalsky AG; Kotula L; Birge RB Oncotarget; 2015 Nov; 6(35):37792-807. PubMed ID: 26473374 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling. Li S; Couvillon AD; Brasher BB; Van Etten RA EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515 [TBL] [Abstract][Full Text] [Related]
11. Direct analysis of the binding of the abl Src homology 2 domain to the activated epidermal growth factor receptor. Zhu G; Decker SJ; Mayer BJ; Saltiel AR J Biol Chem; 1993 Jan; 268(3):1775-9. PubMed ID: 7678409 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134 [TBL] [Abstract][Full Text] [Related]
14. Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nck. Smith JM; Katz S; Mayer BJ J Biol Chem; 1999 Sep; 274(39):27956-62. PubMed ID: 10488144 [TBL] [Abstract][Full Text] [Related]
15. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding. Chen S; Brier S; Smithgall TE; Engen JR Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393 [TBL] [Abstract][Full Text] [Related]
16. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Wen ST; Van Etten RA Genes Dev; 1997 Oct; 11(19):2456-67. PubMed ID: 9334312 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase. Oda T; Kujovich J; Reis M; Newman B; Druker BJ Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]